NCT07508540

Brief Summary

This prospective multicenter study evaluated the construct validity and responsiveness of the Fugl-Meyer Assessment (FMA) in individuals with subacute stroke undergoing inpatient rehabilitation. A total of over 100 participants were assessed at admission and discharge using FMA alongside established clinical measures and patient-reported anchors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

2.5 years

First QC Date

March 17, 2026

Last Update Submit

March 27, 2026

Conditions

Keywords

strokerehabilitationMeasurement Properties

Outcome Measures

Primary Outcomes (2)

  • Fugl Meyer Assessment

    A stroke-specific scale evaluating motor function, sensory function, joint range of motion, and pain in upper and lower limbs. It provides detailed assessment of motor impairment severity.

    Baseline

  • Fugl-Meyer Assessment

    A stroke-specific scale evaluating motor function, sensory function, joint range of motion, and pain in upper and lower limbs. It provides detailed assessment of motor impairment severity.

    after 3 weeks

Secondary Outcomes (8)

  • Modified Barthel Index

    Baseline

  • Modified Barthel Index

    after 3 weeks

  • Motricity Index

    Baseline

  • Motricity Index

    after 3 weeks

  • Functional Ambulation Category

    Baseline

  • +3 more secondary outcomes

Study Arms (1)

Subacute Stroke Cohort

Participants with subacute stroke undergoing inpatient rehabilitation. All participants are assessed at admission and discharge using the Fugl-Meyer Assessment and additional clinical outcome measures to evaluate motor function, construct validity, and responsiveness over time. No intervention-based group allocation is performed, as this is an observational study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult individuals with a diagnosis of stroke and resulting hemiparesis, referred from acute care hospitals to inpatient rehabilitation units. Participants are in the subacute phase of stroke recovery and present with residual motor impairment affecting upper and/or lower limb function, as well as limitations in activities of daily living. Patients are consecutively recruited from specialized neurorehabilitation centers providing intensive, multidisciplinary rehabilitation programs. The population reflects a typical clinical sample of individuals undergoing inpatient rehabilitation after stroke, with a wide range of motor impairment severity and functional limitations.

You may qualify if:

  • Age ≥ 18 years
  • Diagnosis of stroke with resulting hemiparesis
  • stroke outcomes with the presence of sensorimotor impairment affecting the upper and/or lower limb
  • Admission to inpatient rehabilitation in the subacute phase of stroke
  • Ability and willingness to provide informed consent

You may not qualify if:

  • Severe or uncorrected visual or hearing impairments interfering with assessment
  • Cognitive or language impairments preventing understanding or execution of study procedures
  • Clinical instability, defined as a Clinical Instability Scale (CIS) score \> 0
  • Any medical condition preventing safe participation in rehabilitation or assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Fondazione Don Gnocchi

Florence, Florence, 50143, Italy

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2026

First Posted

April 2, 2026

Study Start

July 1, 2023

Primary Completion

December 20, 2025

Study Completion

January 1, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to privacy and ethical restrictions related to sensitive clinical data. Data are stored in a secure environment and are accessible only to authorized study personnel.

Locations